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Abstract
Protein  engineering  is  the  novel  field  which  has  wide  applications  from 
pharmaceutics,  industry,  commercial,  laundry and research.  It  may apply rational 
design  or  non  rational  design  or  both.  Site  directed  mutagenesis  is  a  classical 
approach involving the protein folding principles and as such different techniques 
involving  multidisciplinary  research  and  broad  knowledge  is  required  involving 
biocomputing  of  complex  data  obtained  from  various  sequencing  projects  and 
prediction of the future protein structure either chemically or genetically modified. 
Non rational mutagenesis or directed evolution involves random mutations in the 
gene encoding protein or shuffling the genes encoding different domains producing 
a  random  set  of  numerous  large  libraries  of  mutant  proteins,  using  advanced 
technology the desired protein can be selected but the exact structure or changes 
may remain unnoticed. 
Introduction
Protein engineering aims at modifying the sequence of a protein, to produce 
novel molecules either having some new functions by doing mutagenesis or creating 
completely novel  protein molecules,  in  order to  get  a better  understanding of  its 
structure- activity relationship, and control a protein’s function by obtaining a desired 
change  in  its  activity.  Protein  engineering  is  considered  as  a  second  wave  of 
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innovation after genetic engineering. It is useful for studies of basic research and 
application, in structure-function relations and for exploitation in industry.  Genetic 
engineering provides proteins in bulk which are processed and redesigned to make 
them suitable for pharmaceutical and industrial requirements (Protein engineering in 
Albherghina, 2000). Protein engineering is a coordinated application of a number of 
disciplines  usually  referred  to  as  the  cycle  of  protein  engineering  (fig.  1)  like 
determination  of  prediction  of  protein  conformation  (secondary  and  tertiary),  
experimental studies of  protein folding, chemical modification, mutagenesis (general 
and   site  specific)  and  physical/biochemical  methods  for  structure-activity 
relationships.
Fig 1: The Cycle of Protein Engineering 
The  first  step  in  protein  engineering  is  mutagenesis,  which  requires  DNA 
sequences cloned from original source or DNA synthesized on the protein sequence 
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of  interest.  There  are  two  main  methods  of  mutagenesis.  (a)  Site  directed 
mutagenesis and (b) Random mutagenesis.
Experimental approaches for protein engineering
The experimental approaches for protein engineering are;(Table 1).
(i) Rational design
(ii) Molecular evolution 
(iii) Generation of random libraries
(iv) De novo protein design
(i) Rational Design/ Rational Mutagenesis/ Site Directed  Mutagenesis 
(SDM):
Chemical or synthetic modification of protein
Proteins play many roles in cellular physiology, serving as structural building 
blocks,  catalyzing  biochemical  reactions,  performing  regulatory  functions  and,  in 
combination with other proteins, self-assembling into complex molecular machines, 
such as the contractile fibres that are involved in cell motility or the channels that 
control ion flow across cell membranes. Protein engineering, which first emerged in 
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the early 1980s, involves the use of chemical or genetic techniques to modify the 
structure  of  a  protein,  thereby  increasing  its  stability  or  altering  its  physiological 
function  or  activity  In  protein  engineering,  using  x-ray  crystallography,  chemical 
synthesis of DNA, and computer modelling of protein structure and folding has made 
it possible to attempt to modify many different properties of proteins by combining 
information on crystal structure and protein chemistry with artificial gene synthesis.  
Such techniques offer the potential for altering protein structure and function in ways 
not possible by any other method (Carter, 1986).
Site directed mutagenesis
Site directed mutagenesis is a classical approach, introducing a change in 
one/more amino acids and evaluate the effect in mutated product e.g.; Influencing 
the regulation of a protein. This method required a prior knowledge of the protein or  
role played by specific residues or regions of the protein, availability of the protein 
3D-structure  if  possible  along  substrate,  ligands  regulation  elements  or  at  least 
another related protein for comparison, in order to make the desired changes. It may 
need sequence alignment to support the selection of positions to mutate, particularly 
when the protein belongs to large well  characterized family of  proteins and then 
predict  the  function  effects  of  planed  substitutions.  This  method  has  achieved 
important goals. It is easy, in expensive and well developed. But it is not easy to get 
the detailed knowledge of the protein or predict the effect of various mutations. 
The nucleotide sequence of a cloned DNA fragment may be changed at will by site-
directed mutagenesis using synthetic oligonucleotides (Smith, 1985). 
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 (ii) Non-rational  design/ random design/ directed evolution
Random mutagenesis  on whole  protein  sequences or  parts  thereof  is  the 
method  of  choice  in  all  those  cases  where  knowledge  about  the  structure  and 
function  of  the  protein  of  interest  is  not  sufficient  to  support  a  rational  design 
approach. The most innovative techniques involve the
generation  of  repertoires  (libraries)  of  mutated  sequences  and  procedures  of 
mutation/selection that mimic the processes followed by nature during evolution. In 
both  cases,  a  very  high  number  of  mutant  variants  is  produced,  so  that  the 
development and availability of sensitive and fast procedures of screening is vital to  
manage the experimental work.
(A) DNA shuffling
DNA shuffling (Stemmer.,  1994a and b).  This  technique is  also known as 
“sexual  PCR”.  A  final  step  of  amplification  with  primers  generates  full-length 
products.  The  activity  of  β-lactamase  towards  the  antibiotic  cefotaxime  was 
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increased  over  16,000  times  through  three  cycles  of  sexual  PCR,  whereas  the 
fluorescence of the green fluorescent protein was increased 45 fold (Crameri et al.,  
1996).
(B) Directed evolution
In  vitro  directed  evolution  is  another  powerful  approach,  developed  by 
F.Arnold at Caltech, which, with repetitive cycles of mutagenesis/screening forces 
the evolution of the selected sequence towards the desired functions (Arnold, 1996). 
Differently  from  DNA  shuffling,  in  this  approach  after  every  cycle  of  random 
mutagenesis, only a single variant showing functional improvements is selected and 
used as the parent for the next generation of mutants. An esterase from  Bacillus 
subtilisvtas modified as to become able to hydrolyze pnitrobenzyl ester bonds in the 
presence of organic solvents, a reaction of interest for the pharmaceutical industry to 
remove protecting groups introduced during the synthesis of antibiotics of the class 
of  cephalosporins.  Specific  activity  was  increased  of  30-folds  through  four 
generations of  random mutagenesis followed by DNA recombination (Moore and 
Arnold, 1996). Even the specific activity of subtilisin E in polar solvent was enhanced 
through  the  same  approach  (Chen  and  Arnold,  1993).  Another  property  of 
paramount  importance  in  biotechnology—enantioselectivity—  was  introduced  by 
directed evolution in a lipase from Pseudomonas aeruginosa (Reetz et al., 1997).
Structures and modelling
Besides developments in molecular biology and biochemistry, biocomputing 
and methods for the determination of 3D structures, are indispensable tools in this 
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field. Since the three-dimensional structure of a protein (enzyme, hormone, receptor) 
determines its  biological  function,  it  becomes important  to  have available  a high 
resolution 3D structure, especially when the protein engineer aims to redesigning the 
protein function. 
Medium engineering and bioimprinting
Often enzymes exposed to particular pH or ligands before liophylization and 
subsequent  dissolution  in  organic  solvents,  prove  to  be  able  to  retain  specific 
properties, i.e affinity for the ligand, a property referred to as “memory”. Based on 
this observation, a strategy for the activation of proteins has been developed which 
was called “molecular (bio) imprinting” and can be adapted to particular conditions 
where  the  reaction  of  interest  has  to  take  place.  The  ability  to  use  proteins  in 
unusual or nonnatural environments greatly expands their potential applications in 
biotechnology (Arnold, 1993).
Engineering specificity
Rational  design,  random  mutagenesis  as  well  as  molecular  evolution 
techniques, have all  been applied in the effort of controlling protein specificity.  A 
common approach towards redesigning enzyme specificity is that of using existing 
protein (Shao and Arnold, 1996). 
Engineering feature to ease protein purification
Tags are introduced to obtain enzymes in poure form specially in industry. 
Two  contribution  of  this  volume  specifically  focus  on  the  introduction  of  “tags” 
allowing purification and folding of the protein of interest. Hober and Uhlen describe 
the use of fusion proteins and co-expression strategies to ease folding and recovery 
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of  recombinant  proteins.  Schmidt  and  Skerra  developed  by  molecular  repertoire 
techniques a novel tag able to bind with high affinity to streptavidin from where it can 
be eluted by competition with biotin analogues.
Artificial  non  antibody  binding  proteins  (Affibodies) Combinatorial 
proteins/fusion proteins  for pharmaceutical and industrial applications
Using  combinatorial  chemistry  to  generate  novel  non  antibody  binding 
molecules based on protein  frameworks (‘scaffolds’)  is  a  concept  that  has been 
strongly promoted during the past five years in both academia and industry and 
attempts  are  made  to  engineer  affinity  to  perfection.  Nonantibody  recognition 
proteins derive from different structural families and mimic the binding principle of 
immunoglobulins to varying degrees. In addition to the specific binding of a pre-
defined target, these proteins provide favourable characteristics such as robustness, 
ease of modification and cost-efficient production. The broad spectrum of potential  
applications, including research tools, separomics, diagnostics and therapy, has led 
to  the commercial  exploitation of  this  technology by various small-  and medium-
sized companies. It  is predicted that scaffold-based affinity reagents will  broaden 
and complement applications that are presently covered by natural or recombinant 
antibodies. (Thomas et al., 2005).
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